Dr. Ajay Sharma – Senior Director & Unit Head Medical Oncology, BLK-Max Super Speciality Hospital New Delhi India

Dr. Ajay Sharma [MBBS, MD - Medicine, DNB - Medical Oncology]

International Patient Helpdesk: +918860606766, ‪+91-9910655125

Experience:

 25 Year

Specialization:

  Medical Oncology,

Hospitals:

  BLK-Max Super Speciality Hospital, New Delhi

Google Location:

BLK-Max Super Speciality Hospital, 5, Pusa Road, New Delhi, Delhi 110005


  • Dr. Ajay Sharma is a Medical Oncologist and currently working as Senior Director and Unit Head in the Medical Oncology Department at BLK-Max Super Speciality Hospital, Pusa Road, New Delhi, India.
  • With over 25 years of experience in Medical Oncology, Dr. Sharma is one of Delhi's most accomplished and widely recognised cancer specialists — having served as Unit Head and Senior Consultant at the Rajiv Gandhi Cancer Institute & Research Centre (RGCI), Principal Consultant at the Max Institute of Cancer Care (Max Super Speciality Hospital, Shalimar Bagh), and Unit Head at Action Cancer Hospital before joining BLK-Max.
  • He completed his MBBS from Jammu University (2001), MD in Medicine from Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar (2006) and DNB in Medical Oncology from the National Board of Examinations (2011) — building a comprehensive academic foundation across three of North India's most respected medical institutions.
  • Dr. Sharma is a prolific researcher — he is an author of 40+ international and national publications (including contributions to Annals of Oncology) and has served as Principal Investigator in 20+ national and international clinical trials — placing him at the forefront of oncology research and evidence-based cancer treatment in India.
  • He has received a Certification from the European Society of Medical Oncology (ESMO) in 2013 from Amsterdam and presented his research on Eribulin in Advanced Breast Cancer at the ESMO-2017 Congress in Madrid, Spain — demonstrating recognition at the highest levels of global oncology.
  • International patients from the Middle East, Africa, South Asia and Central Asia choose BLK-Max Super Speciality Hospital and Dr. Ajay Sharma for chemotherapy, targeted therapy, immunotherapy and complex cancer management at significantly lower costs than Western countries, with outcomes matching international standards.

Area of Expertise:

  • Targeted Therapy for Solid Tumours (Breast, Lung, GI, GU, Head & Neck, Sarcomas)
  • Intensive Immunotherapy Protocols
  • Hormonal Therapy (Breast, Prostate Cancer)
  • Haematological Malignancies — Leukaemia, Lymphoma, Multiple Myeloma
  • Chemotherapy via Central Lines (PICC, Chemo Port)
  • Regional Chemotherapy (Intraperitoneal, Intrathecal)
  • Blood Cancer Management — ALL, AML, CLL, CML, CMML
  • Hodgkin & Non-Hodgkin Lymphoma
  • Symptom Palliation & Supportive Oncology Care
  • Cancer Management in Complex Multi-System Cases

  • Chemotherapy (Solid Tumours & Blood Cancers)
  • Targeted Therapy
  • Immunotherapy (Checkpoint Inhibitors)
  • Hormonal Therapy (Breast & Prostate Cancer)
  • Chemo Port / PICC Line Insertion
  • Intraperitoneal Chemotherapy
  • Intrathecal Chemotherapy
  • Breast Cancer Treatment
  • Lung Cancer Treatment
  • GI Cancer Chemotherapy (Stomach, Colon, Pancreas)
  • Head & Neck Cancer Chemotherapy
  • Leukaemia Treatment (ALL, AML, CLL, CML)
  • Lymphoma Treatment (Hodgkin, Non-Hodgkin)
  • Multiple Myeloma Treatment
  • Sarcoma Chemotherapy
  • Palliation & Supportive Care
  • Senior Director and Unit Head – Medical Oncology — BLK-Max Super Speciality Hospital, Pusa Road, New Delhi (Current)
  • Unit Head and Senior Consultant – Medical Oncology — Rajiv Gandhi Cancer Institute & Research Centre (RGCI), New Delhi (Aug 2022 – Sep 2023)
  • Principal Consultant – Medical Oncology — Max Institute of Cancer Care, Max Super Speciality Hospital, Shalimar Bagh, New Delhi (Dec 2020 – Aug 2022)
  • Unit Head – Medical Oncology — Action Cancer Hospital, Paschim Vihar, New Delhi (Dec 2016 – Nov 2020)
  • Consultant – Medical Oncology — Rajiv Gandhi Cancer Institute & Research Centre (RGCI), New Delhi (Oct 2014 – Nov 2016)
  • Consultant – Medical Oncology — Action Cancer Hospital, Paschim Vihar, New Delhi (Jun 2011 – Oct 2014)
  • Associate Consultant – Medical Oncology — Rajiv Gandhi Cancer Institute & Research Centre (RGCI), New Delhi (Aug 2010 – Jun 2011)
  • MBBS — Jammu University, 2001
  • MD – Medicine — Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar (Deemed University), 2006
  • DNB – Medical Oncology — National Board of Examinations (NBE), New Delhi, 2011

Memberships & Affiliations:

  • European Society of Medical Oncology (ESMO) — Certified Member (2013)
  • American Society of Clinical Oncology (ASCO)
  • Indian Society of Medical & Paediatric Oncology (ISMPO)
  • Delhi Medical Council — Registration No. 33451
  • Senior Director and Unit Head — Medical Oncology, BLK-Max Super Speciality Hospital (Current)
  • ESMO (European Society of Medical Oncology) Certification — Amsterdam, Netherlands, 2013
  • 40+ international and national research publications including in Annals of Oncology
  • Principal Investigator in 20+ national & international clinical trials

Research Papers & Presentations:

  • Paper Presentation — "Eribulin Mesylate in Advanced Breast Cancer" — ESMO Asia Congress, Singapore, 2016
  • Paper Presentation — Data on Eribulin — ESMO-2017 Congress, Madrid, Spain
  • Research Paper — "Dasatinib in CML Patients" — Annals of Oncology, 2009
  • 40+ further publications in national & international oncology journals
  • 100+ academic conference presentations and CME involvements
BLK-Max Super Speciality Hospital, 5, Pusa Road, New Delhi, Delhi 110005

Frequently Asked Questions

Dr. Ajay Sharma is Senior Director and Unit Head — Medical Oncology at BLK-Max Super Speciality Hospital, New Delhi. With 25+ years of experience, he is one of Delhi's most accomplished cancer specialists, having previously served as Unit Head at the Rajiv Gandhi Cancer Institute and Principal Consultant at Max Institute of Cancer Care, Shalimar Bagh. He has authored 40+ international publications and served as Principal Investigator in 20+ clinical trials.

Related Doctors

TOP HOSPITALS

Special High-quality Hospitals


HAPPY PATIENTS

What Our Patients Are Saying

Our Gallery


Request a Call Back

WhatsApp Us